Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive radical treatment, despite the high mortality associated with conservative management.
To investigate how age and comorbidity affect treatment of men with HRnMPCa.
This was an observational nationwide register study during 2001-2012. We identified 19 190 men of